LN-504434
PalBociclib Impurity 23 , 0.95 , 2205035-04-5
Update time: 2023-04-23
PRODUCT Properties
| Boiling point: | 694.5±65.0 °C(Predicted) |
| Density | 1.313±0.06 g/cm3(Predicted) |
| pka | 8.63±0.10(Predicted) |
Description and Uses
Palbociclib Impurity A is related to the parent compound, Palbocicib (P139900) (also known as compound number PD-0332991), which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.Also, it is derived from 3-Fluoro-2-nitropyridine (F597685).
